Skip to main content
Top
Published in: Digestive Diseases and Sciences 2/2007

01-02-2007 | Case Report

Type II Hereditary Angioedema—Presenting as Food Allergy

Authors: Yvonne Williams, Greg Byrne, Sara Lynch, Conleth Feighery, Mohamed Abuzakouk

Published in: Digestive Diseases and Sciences | Issue 2/2007

Login to get access

Excerpt

Hereditary angioedema (HAE) is caused by a genetic defect of C1 inhibitor (C1INH), a control protein of the classical complement pathway. In the majority of cases the disease is inherited in an autosomal dominant manner, however, up to 25% of patients may present with a de novo mutation. It is well established that approximately 85% of patients have low or undetectable levels of C1INH (type I HAE), however, 15% of patients can present with normal or increased levels of dysfunctional C1INH (type II HAE). The clinical manifestations of both types of HAE are very similar and are due to uncontrolled activation of the complement pathway. The characteristic clinical presentation is recurrent episodes of angioedema affecting different parts of the body including the face, hands, feet, upper airways, and abdomen. The disease has a prevalence of 1 in 50,000 and can often be misdiagnosed. While most children will have had at least one episode before the teenage years, many are not diagnosed until the second or third decade [1]. …
Literature
1.
go back to reference Fay A, Abinun D (2002) Current management of hereditary angioedema (C’1 esterase inhibitor deficiency). J Clin Pathol 55:266–270PubMed Fay A, Abinun D (2002) Current management of hereditary angioedema (C’1 esterase inhibitor deficiency). J Clin Pathol 55:266–270PubMed
2.
go back to reference Blanch A, Roche O, López-Granados E, Fontán G, López-Trascasa M (2002) Detection of C1 inhibitor (SERPING1/C1INH) mutations in exon 8 in patients with hereditary angioedema: evidence for 10 novel mutations. Human Mutation: Mutation in Brief 544 (online) Blanch A, Roche O, López-Granados E, Fontán G, López-Trascasa M (2002) Detection of C1 inhibitor (SERPING1/C1INH) mutations in exon 8 in patients with hereditary angioedema: evidence for 10 novel mutations. Human Mutation: Mutation in Brief 544 (online)
3.
go back to reference Stein PE, Carrell RW (1995) What do dysfunctional serpins tell us about molecular mobility and disease? Nat Struct Biol 2:96–113PubMedCrossRef Stein PE, Carrell RW (1995) What do dysfunctional serpins tell us about molecular mobility and disease? Nat Struct Biol 2:96–113PubMedCrossRef
4.
go back to reference Sim TC, Grant JA (1990) Hereditary angioedema: its diagnostic and management perspectives. JAMA 88:656–664 Sim TC, Grant JA (1990) Hereditary angioedema: its diagnostic and management perspectives. JAMA 88:656–664
5.
go back to reference Marenah CB, Quiney JR (1983) C1 esterase inhibitor deficiency as a cause of abdominal pain. BMJ 286:786–787PubMedCrossRef Marenah CB, Quiney JR (1983) C1 esterase inhibitor deficiency as a cause of abdominal pain. BMJ 286:786–787PubMedCrossRef
6.
go back to reference Gompels MM, Lock RJ, Morgan JE, et al. (2002) A multi-centre evaluation of the diagnostic efficiency of serological investigations for C1 inhibitor deficiency. J Clin Pathol 55:145–147PubMedCrossRef Gompels MM, Lock RJ, Morgan JE, et al. (2002) A multi-centre evaluation of the diagnostic efficiency of serological investigations for C1 inhibitor deficiency. J Clin Pathol 55:145–147PubMedCrossRef
7.
go back to reference Karim Y, Griffiths H, Deacock S (2004) Normal complement C4 values do not exclude hereditary angioedema. J Clin Pathol 57(2):213–214PubMedCrossRef Karim Y, Griffiths H, Deacock S (2004) Normal complement C4 values do not exclude hereditary angioedema. J Clin Pathol 57(2):213–214PubMedCrossRef
8.
go back to reference Morrison RC, Rabson AR (1987) The late onset form of C1 esterase-inhibitor deficiency presenting as food allergy. J Allergy Clin Immunol 79(2):336–339PubMedCrossRef Morrison RC, Rabson AR (1987) The late onset form of C1 esterase-inhibitor deficiency presenting as food allergy. J Allergy Clin Immunol 79(2):336–339PubMedCrossRef
9.
go back to reference Farkas H et al (2002) Association of coeliac disease and hereditary angioneurotic oedema. AJG 10:2682–2683 Farkas H et al (2002) Association of coeliac disease and hereditary angioneurotic oedema. AJG 10:2682–2683
10.
go back to reference Rostom A, Dubé C, Cranney A, Saloojee N, Richmond S, Garritty C, Sampson M, Zhang L, Yazdi F, Mamaladze V, Pan I, MacNeil J, Mack D, Patel D, Moher D (2005) The diagnostic accuracy of serologic tests for celiac disease: a systematic review. Gastroenterology 128(4 S1):S38–S46 Rostom A, Dubé C, Cranney A, Saloojee N, Richmond S, Garritty C, Sampson M, Zhang L, Yazdi F, Mamaladze V, Pan I, MacNeil J, Mack D, Patel D, Moher D (2005) The diagnostic accuracy of serologic tests for celiac disease: a systematic review. Gastroenterology 128(4 S1):S38–S46
11.
go back to reference Carroccio A, Iacono G, Montalto G, Cavataio F, Soresi M, Kazmierska I, Notarbartolo A (1993) Immunologic and absorptive tests in celiac disease: Can they replace intestinal biopsies? Scand J Gastroenterol 28(8):673–676PubMed Carroccio A, Iacono G, Montalto G, Cavataio F, Soresi M, Kazmierska I, Notarbartolo A (1993) Immunologic and absorptive tests in celiac disease: Can they replace intestinal biopsies? Scand J Gastroenterol 28(8):673–676PubMed
12.
go back to reference Lawrence C, Abdrabbo MK (2003) Angioedema as a complication of upper endoscopy. Ann Intern Med 139(3):E237–E238PubMed Lawrence C, Abdrabbo MK (2003) Angioedema as a complication of upper endoscopy. Ann Intern Med 139(3):E237–E238PubMed
13.
go back to reference Yakel DL Jr, Whittaker SE, Elstad MR (1992) Midazolam-induced angioedema and bronchoconstriction. Crit Care Med 20:307–308PubMedCrossRef Yakel DL Jr, Whittaker SE, Elstad MR (1992) Midazolam-induced angioedema and bronchoconstriction. Crit Care Med 20:307–308PubMedCrossRef
14.
go back to reference Cicardi M, Agostoni A (1996) Hereditary angioedema. N Engl J Med 334:166–167CrossRef Cicardi M, Agostoni A (1996) Hereditary angioedema. N Engl J Med 334:166–167CrossRef
15.
go back to reference Schuppan D, Dennis MD, Kelly CP (2005) Celiac disease: epidemiology, pathogenesis, diagnosis, and nutritional management. Nutr Clin Care 8(2):54–69PubMed Schuppan D, Dennis MD, Kelly CP (2005) Celiac disease: epidemiology, pathogenesis, diagnosis, and nutritional management. Nutr Clin Care 8(2):54–69PubMed
17.
go back to reference Davis AE 3rd, Cai S, Liu D (2003) The biological role of the c1 inhibitor. Transfus Apheresis Sci 29:195–203CrossRef Davis AE 3rd, Cai S, Liu D (2003) The biological role of the c1 inhibitor. Transfus Apheresis Sci 29:195–203CrossRef
Metadata
Title
Type II Hereditary Angioedema—Presenting as Food Allergy
Authors
Yvonne Williams
Greg Byrne
Sara Lynch
Conleth Feighery
Mohamed Abuzakouk
Publication date
01-02-2007
Published in
Digestive Diseases and Sciences / Issue 2/2007
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-006-9294-y

Other articles of this Issue 2/2007

Digestive Diseases and Sciences 2/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine